Table 1. Summary of the main characteristics of studies that applying autofluorescence to detect OSCC and OPMD.
First Author | Year | Country | Sample Size | TP | FP | FN | TN |
---|---|---|---|---|---|---|---|
Onizawa K48 | 1996 | Japan | 32 | 14 | 1 | 2 | 15 |
Gillenwater A49 | 1998 | USA | 28 | 16 | 0 | 1 | 11 |
Wang CY50 | 1999 | China | 32 | 13 | 1 | 3 | 15 |
Onizawa K51 | 1999 | Japan | 124 | 75 | 2 | 5 | 42 |
van Staveren HJ52 | 2000 | Netherlands | 28 | 19 | 0 | 3 | 6 |
Wang CY53 | 2003 | China | 97 | 21 | 3 | 5 | 68 |
Muller MG54 | 2003 | USA | 74 | 27 | 1 | 2 | 44 |
Majumder SK55 | 2003 | India | 325 | 78 | 9 | 5 | 233 |
Svistun E56 | 2004 | USA | 23 | 15 | 1 | 1 | 6 |
Majumder SK57 | 2005 | India | 325 | 74 | 16 | 9 | 146 |
Poh CF16 | 2006 | Canada | 122 | 52 | 4 | 1 | 65 |
Lane PM21 | 2006 | Canada | 50 | 43 | 0 | 1 | 6 |
Jayaprakash V58 | 2009 | USA | 249 | 123 | 40 | 47 | 39 |
Roblyer D20 | 2009 | USA | 159 | 69 | 5 | 2 | 83 |
Koch FP59 | 2010 | Germany | 78 | 31 | 37 | 2 | 8 |
Mehrotra R60 | 2010 | India | 156 | 6 | 88 | 6 | 56 |
Awan K.H.19 | 2011 | United Kingdom | 116 | 37 | 61 | 7 | 11 |
Scheer M61 | 2011 | Germany | 64 | 12 | 10 | 0 | 42 |
Matsumoto K62 | 2011 | Japan | 74 | 39 | 8 | 25 | 2 |
Farah CS29 | 2012 | Australia | 118 | 8 | 34 | 19 | 57 |
Hanken H63 | 2013 | Germany | 60 | 47 | 8 | 1 | 4 |
Jayaprakash V64 | 2013 | USA | 255 | 164 | 59 | 20 | 12 |
Piazza C65 | 2013 | Italy | 116 | 66 | 13 | 18 | 19 |
Petruzzi M66 | 2014 | Italy | 56 | 21 | 11 | 9 | 15 |
TP: true positive; FP: false positive; FN: false negative; TN: true negative; OSCC: oral squamous cell carcinoma; OPMD: oral potentially malignant disorders.